Cancer now kills more Hispanic and Latino Americans than any other disease, and much of that toll comes from cancers doctors know how to catch early or prevent outright.
Story Snapshot
- A new American Cancer Society report finds cancer is the leading cause of death among Hispanic and Latino people in the United States.
- The group faces higher death rates from cervical, liver, and stomach cancers compared to non-Hispanic White Americans, even though overall cancer death rates are lower.
- The American Cancer Society estimates 195,300 new cancer cases and 50,400 cancer deaths among Hispanic people in 2024.
- Researchers point to screening gaps, delayed treatment, and limited health care access as key drivers behind the preventable-cancer burden.
What The New Report Actually Found
The American Cancer Society published its findings through its press office and in the peer-reviewed journal CA: A Cancer Journal for Clinicians, giving the numbers real scientific weight rather than just a press release claim. The report states cancer was the top killer of Hispanic Americans from 2009 through 2019, a twelve-year stretch covering more than a decade of consistent data collection and death-record analysis.
Heart disease remains the number one killer for the US population overall and for non-Hispanic White Americans. But cancer pulls ahead among Hispanic people, partly because this population skews younger on average, and cancer tends to strike before heart disease catches up in later decades of life.
Why Some Cancers Hit Harder Than Others
Here is the twist that makes this report worth a second look. Hispanic Americans actually have lower overall cancer death rates than non-Hispanic White Americans. Yet for three specific cancers, cervical, liver, and stomach, the death rates flip higher, sometimes dramatically. Stomach cancer death rates alone run roughly 51 percent higher for Hispanic men and 80 percent higher for Hispanic women compared to the general population.
These three cancers share something important: all three are largely preventable or catchable early. Cervical cancer can be stopped with the HPV vaccine and regular Pap smears. Liver cancer often traces back to untreated hepatitis infections. Stomach cancer links to H. pylori bacteria, which doctors can test for and treat with antibiotics. When these tools reach patients early, death rates drop sharply.
The Access Gap Behind The Numbers
The American Cancer Society’s own materials point to access and structural barriers as explanations for the gap, not biology or genetics. Hispanic patients are more likely to lack health insurance, more likely to live in poverty, and more likely to face language or transportation barriers that delay screening and treatment. Hispanic Americans also underuse colorectal cancer screening compared to non-Hispanic White patients, a pattern researchers link to the same access barriers driving other preventable-cancer deaths.
Delayed diagnosis matters enormously in cancer outcomes. A tumor caught at stage one often means outpatient treatment and a good prognosis. The same tumor caught at stage four can mean months of aggressive treatment with far worse odds. Hispanic patients are more likely to be diagnosed at advanced stages, which compounds every other disadvantage tied to access and insurance coverage.
A Note On Shifting Rankings
Readers should know cancer’s ranking as the top killer among Hispanic Americans has shifted in recent years. The COVID-19 pandemic temporarily pushed cancer to second place behind heart disease in 2022, reflecting how pandemic deaths disproportionately struck Hispanic communities during those years. The American Cancer Society’s longer-term framing, covering 2009 through 2019, still holds as the backbone of the report’s core finding.
What This Means Going Forward
This report should be a wake-up call, not a cause for despair. Nearly every cancer type driving this disparity responds to known, affordable interventions: vaccines, screenings, and early antibiotic treatment. That is good news wrapped inside hard statistics. The policy question now facing community health clinics, insurers, and lawmakers is simple: how fast can screening and vaccination reach the Hispanic communities currently falling through the cracks.
Expanding access through community clinics, price transparency, and competition beats top-down mandates. This report offers a clear test case. Lower overall cancer death rates among Hispanic Americans show resilience and strong family health habits already exist in these communities. Closing the three preventable-cancer gaps means delivering tools people already want, not inventing new bureaucracy to convince them.
